Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver 3 Days of Expert-Led Content to Advance Autoimmune TCE Strategy

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

Sony and Astellas Enter into Collaborative Research Agreement to Discover a Novel ADC Platform for the Oncology Field

Read more

uniQure Announces Sale of Royalty Interest in HEMGENIX for Up To $400 Million

Read more

Gilead Sciences and Arcus Biosciences Expand Partnership to Include Research Programs in Inflammation

Read more

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

Read more

Sobi to acquire CTI BioPharma Corp. enhancing Sobi’s position in rare haematology

Read more

Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)

Read more

Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology

Read more

Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application (sNDA) for REXULTI (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease

Read more

FDA accepts application for Roche’s Vabysmo for the treatment of retinal vein occlusion (RVO)

Read more

AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN’S DISEASE

Read more

Posts pagination

Previous Page 1 of 946 … Page 187 of 946 … Page 946 of 946 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version